Mr. Gibson joins PacBio from Sequoia, a strategic compensation and benefits solutions provider, where he served as CFO across four entities. Prior to Sequoia, Mr. Gibson was CFO at Willow Innovations, ...

Sequencing solutions provider Pacific Biosciences of California (PACB) announced on Thursday the appointment of Jim Gibson to the post of CFO, effective March 31.

Scotiabank analyst Sung Ji Nam lowered the firm’s price target on PacBio (PACB) to $2 from $6 and keeps an Outperform rating on the shares. The ...

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports.

At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $2.04, a high estimate of $2.50, and a low estimate of $1.50.

Scotiabank analyst Sung Ji Nam maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

At close: March 28 at 4:00:01 PM EDT ...